APPLICATION SITE ANAESTHESIA side effect
What is APPLICATION SITE ANAESTHESIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
APPLICATION SITE ANAESTHESIA and Recently Reported Side Effects
APPLICATION SITE ANAESTHESIA and 15 most Active Side Effect polls
APPLICATION SITE ANAESTHESIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with APPLICATION SITE ANAESTHESIA
ABREVA CELLUVISC DURAGESIC NEOMYCIN NORPLANT VOLTARENNorplant Side Effects Report #5528366-X
Health Professional from UNITED STATES reported NORPLANT SYSTEM problem on Nov 26, 2007. Female patient, weighting 142.1 lb, was diagnosed with contraception, hypothyroidism and was treated with NORPLANT SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, headache, nervous system disorder, . NORPLANT SYSTEM dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, RISPERDAL. Patient recovered.
Voltaren Side Effects Report #5475385-8
VOLTAREN problem was reported by a Consumer or non-health professional from BRAZIL on Sept 26, 2007. Female patient, 53 years of age, weighting 198.4 lb, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, application site erythema, application site necrosis, application site pain, gastrointestinal carcinoma, metastases to liver, upper limb deformity, . VOLTAREN dosage: 75 MG/DAY. Patient died on 01/01/2004.
Abreva Side Effects Report #5461277-7
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Sept 04, 2006. Female patient, 46 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462098-1
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Female patient, 19 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, application site swelling, lip swelling, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462871-X
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Mar 30, 2007. Female patient, 59 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, . ABREVA dosage: unknown. Patient recovered.
Duragesic Side Effects Report #5411883-0
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2007. Female patient, weighting 190.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, application site pain, application site pruritus, application site rash, application site reaction, cerebrovascular accident, expressive language disorder, headache, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, CLIMARA. Patient recovered.
Norplant Side Effects Report #5417859-1
Physician from UNITED STATES reported NORPLANT SYSTEM problem on Aug 09, 2007. Female patient, weighting 142.1 lb, was diagnosed with contraception, hypothyroidism and was treated with NORPLANT SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, headache, nervous system disorder, . NORPLANT SYSTEM dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, RISPERDAL. Patient recovered.
Celluvisc Side Effects Report #5393309-9
CELLUVISC problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Male patient, 46 years of age, weighting 245.0 lb, was diagnosed with dry eye and was treated with CELLUVISC. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, application site irritation, injury, pain, . CELLUVISC dosage: unknown. Patient was hospitalized. Patient recovered.
Celluvisc Side Effects Report #5393309-9
Consumer or non-health professional from UNITED STATES reported CELLUVISC problem on July 19, 2007. Male patient, 46 years of age, weighting 245.0 lb, was diagnosed with dry eye and was treated with CELLUVISC. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, application site irritation, injury, pain, . CELLUVISC dosage: unknown. Patient was hospitalized. Patient recovered.
Duragesic Side Effects Report #5365629-5
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Female patient, weighting 190.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site anaesthesia, application site pain, application site pruritus, application site rash, application site reaction, cerebrovascular accident, expressive language disorder, headache, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, CLIMARA. Patient recovered.
Neomycin Side Effects Report #5565467-4
Consumer or non-health professional from UNITED STATES reported NEOMYCIN AND POLYMXIN B SULPHATES AND HYDROCORTISONE problem on Dec 18, 2006. Female patient, 54 years of age, was diagnosed with vitamin supplementation and was treated with NEOMYCIN AND POLYMXIN B SULPHATES AND HYDROCORTISONE. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, application site anaesthesia, eye irritation, . NEOMYCIN AND POLYMXIN B SULPHATES AND HYDROCORTISONE dosage: unknown. During the same period patient was treated with MACROBID. Patient recovered.